Clinical Trial Update: Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effects of human growth hormone and pioglitazone in overweight, prediabetic adults has completed. The study included obesit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance
• Metabolic Syndrome
• Obesity

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• Somatropin (somatropin)

Snippet

Sponsor: Stanford University | Conditions: Obesity, Metabolic Syndrome | Phase 4 | Status: COMPLETED